Amy H Comander

8PUBLICATIONS

59CO-AUTHORS

Molecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Cancer geneticsLiquid biopsies

Get your video featured.

Publish with JoVE

Get your video featured.

Publish with JoVE

Publications (8)

Sort by Publication Date:

|Jul 02, 2026

CDK2 Inhibition Exerts RB-Independent Antitumor Activity in CDK4/6 Inhibitor-Resistant HR+/HER2- Breast Cancer.

|Jun 02, 2026

Applying Lifestyle Medicine to Enhance Cancer Survivorship and Patient Well-being.

|May 13, 2026

Optimizing Breast Cancer Survivorship: Addressing Lifestyle, Weight Management, and Psychological Health.

|Jan 08, 2025

Adjuvant endocrine therapy with cyclin-dependent kinase 4/6 inhibitor, ribociclib, for localized hormone receptor-positive/HER2- breast cancer (LEADER).

Laura M Spring, Lauren Scarpetti, Arielle J Medford

|Nov 03, 2023

Virtual Molecular and Precision Medicine Clinic to Improve Access to Clinical Trials for Patients With Metastatic Breast Cancer: An Academic/Community Collaboration.

Laura M Spring, Lindsey Mortensen, Elizabeth Abraham

|Apr 20, 2022

Pilot study to assess prolonged overnight fasting in breast cancer survivors (longfast).

Elizabeth O'Donnell, Yael Shapiro, Amy Comander

Pageof 2

Frequent Collaborators

Steven J Isakoff

Beverly Moy

Seth A Wander

Aditya Bardia

Leif W Ellisen

Dejan Juric

Elizabeth O'Donnell

Jeffrey Peppercorn

Laura M Spring

Arielle Medford

Frequent Collaborators

Steven J Isakoff

Beverly Moy

Seth A Wander

Aditya Bardia